The epidemiology of HIV/AIDS and the use of antiretroviral therapy in Korea: a narrative review
The availability of combined antiretroviral therapy has significantly reduced the number of new HIV infections and the associated mortality, and HIV infection has become a chronic disease with long-term survival. In Korea, more than 1,000 new...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ewha Womans University College of Medicine
2024-07-01
|
| Series: | The Ewha Medical Journal |
| Subjects: | |
| Online Access: | http://www.e-emj.org/archive/view_article?pid=emj-47-3-36 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846120561598529536 |
|---|---|
| author | Nam Su Ku |
| author_facet | Nam Su Ku |
| author_sort | Nam Su Ku |
| collection | DOAJ |
| description | The availability of combined antiretroviral therapy has significantly reduced the
number of new HIV infections and the associated mortality, and HIV infection has
become a chronic disease with long-term survival. In Korea, more than 1,000 new
HIV infections have been registered annually since 2013. After peaking at 1,223
in 2019, the number of new infections decreased between 2020 and 2023. In 2023,
the majority of newly HIV-infected people were men, and the proportions of young
people under 40 years, homosexual contacts and foreigners increased. Acquired
immunodeficiency syndrome (AIDS)-related deaths from opportunistic infections
associated with immunosuppression and AIDS-defining cancers are gradually
decreasing, whereas non-AIDS defining comorbidities such as non-AIDS defining
cancers, cardiovascular disease and metabolic complications are emerging as
major causes of death. Since the introduction of zidovudine, approximately 30
antiretroviral drugs have been approved for the treatment of HIV infection.
Early and continuous antiretroviral treatment for all people living with HIV is
an effective strategy for maintaining viral suppression and preventing
transmission of HIV infection. In conclusion, achieving the
95–95–95 target among those living with HIV in Korea requires
multifaceted efforts to improve early diagnosis, early and proper treatment of
HIV infection including the management of chronic diseases, and adherence to
antiretroviral therapy. |
| format | Article |
| id | doaj-art-16e11839ea7d4c49aedff23b4a72d56b |
| institution | Kabale University |
| issn | 2234-2591 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Ewha Womans University College of Medicine |
| record_format | Article |
| series | The Ewha Medical Journal |
| spelling | doaj-art-16e11839ea7d4c49aedff23b4a72d56b2024-12-16T08:43:16ZengEwha Womans University College of MedicineThe Ewha Medical Journal2234-25912024-07-0147310.12771/emj.2024.e36emj-47-3-36The epidemiology of HIV/AIDS and the use of antiretroviral therapy in Korea: a narrative reviewNam Su KuThe availability of combined antiretroviral therapy has significantly reduced the number of new HIV infections and the associated mortality, and HIV infection has become a chronic disease with long-term survival. In Korea, more than 1,000 new HIV infections have been registered annually since 2013. After peaking at 1,223 in 2019, the number of new infections decreased between 2020 and 2023. In 2023, the majority of newly HIV-infected people were men, and the proportions of young people under 40 years, homosexual contacts and foreigners increased. Acquired immunodeficiency syndrome (AIDS)-related deaths from opportunistic infections associated with immunosuppression and AIDS-defining cancers are gradually decreasing, whereas non-AIDS defining comorbidities such as non-AIDS defining cancers, cardiovascular disease and metabolic complications are emerging as major causes of death. Since the introduction of zidovudine, approximately 30 antiretroviral drugs have been approved for the treatment of HIV infection. Early and continuous antiretroviral treatment for all people living with HIV is an effective strategy for maintaining viral suppression and preventing transmission of HIV infection. In conclusion, achieving the 95–95–95 target among those living with HIV in Korea requires multifaceted efforts to improve early diagnosis, early and proper treatment of HIV infection including the management of chronic diseases, and adherence to antiretroviral therapy.http://www.e-emj.org/archive/view_article?pid=emj-47-3-36antiretroviral therapyhivnon-aids-defining comorbidities |
| spellingShingle | Nam Su Ku The epidemiology of HIV/AIDS and the use of antiretroviral therapy in Korea: a narrative review The Ewha Medical Journal antiretroviral therapy hiv non-aids-defining comorbidities |
| title | The epidemiology of HIV/AIDS and the use of antiretroviral therapy in
Korea: a narrative review |
| title_full | The epidemiology of HIV/AIDS and the use of antiretroviral therapy in
Korea: a narrative review |
| title_fullStr | The epidemiology of HIV/AIDS and the use of antiretroviral therapy in
Korea: a narrative review |
| title_full_unstemmed | The epidemiology of HIV/AIDS and the use of antiretroviral therapy in
Korea: a narrative review |
| title_short | The epidemiology of HIV/AIDS and the use of antiretroviral therapy in
Korea: a narrative review |
| title_sort | epidemiology of hiv aids and the use of antiretroviral therapy in korea a narrative review |
| topic | antiretroviral therapy hiv non-aids-defining comorbidities |
| url | http://www.e-emj.org/archive/view_article?pid=emj-47-3-36 |
| work_keys_str_mv | AT namsuku theepidemiologyofhivaidsandtheuseofantiretroviraltherapyinkoreaanarrativereview AT namsuku epidemiologyofhivaidsandtheuseofantiretroviraltherapyinkoreaanarrativereview |